Cardiovascular risk profiles in Type 2 diabetes and the impact of geographical setting

References

• International Diabetes Federation. IDF Diabetes Atlas Sixth Edition. Available from: www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf [Last accessed 28 April 2014]
   Google Scholar
• Mu YM, Misra A, Adam JM, et al. Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Res Clin Pract 2012;95(2):179-88
   PubMedGoogle Scholar
• Toyoda K. Epidemiology and Registry Studies of Stroke in Japan. J Stroke 2013;15(1):21-6
   PubMed Web of Science ®Google Scholar
• Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998;22(12):1164-71
   PubMed Web of Science ®Google Scholar
• Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29(24):2959-71
   PubMed Web of Science ®Google Scholar
• World Health Organization Western Pacific Region. The Asia-Pacific perspective: redefining obesity and its treatment. February 2000. Available from: www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf?ua=1 [last accessed 28 April 2014]
   Google Scholar
• Weir MR. Albuminuria predicting outcome in diabetes: incidence of microalbuminuria in Asia-Pacific Rim. Kidney Int Suppl 2004(92):S38-9
   Google Scholar
• Fuller JH, Stevens LK, Wang SL. International variations in cardiovascular mortality associated with diabetes mellitus: the WHO Multinational Study of Vascular Disease in Diabetes. Ann Med 1996;28(4):319-22
   PubMed Web of Science ®Google Scholar
• Schöttker B, Herder C, Müller H, et al. Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes. Diabetes Care 2012;35:879-86
   PubMed Web of Science ®Google Scholar
• Martin S, Kolb H, Schneider B, et al. Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose. Diabetes Technol Ther 2009;11:234-41
   PubMedGoogle Scholar
• Ruggenenti P, Porrini E, Motterlini N, et al. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes. J Am Soc Nephrol 2012;23:1717-24
   PubMed Web of Science ®Google Scholar
• Giunti S, Gruden G, Fornengo P, et al. Increased QT interval dispersion predicts 15-year cardiovascular mortality in type 2 diabetic subjects: the population-based Casale Monferrato Study. Diabetes Care 2012;35:581-3
   PubMedGoogle Scholar
• Panero F, Gruden G, Perotto M, et al. Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. Atherosclerosis 2012;221:183-8
   PubMed Web of Science ®Google Scholar
• Bo S, Gentile L, Castiglione A, et al. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol 2012;167:173-80
   PubMedGoogle Scholar
• Landman GW, van Hateren KJ, Kleefstra N, et al. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract 2010;60(572):172-5
   PubMedGoogle Scholar
• Lind M, Olsson M, Rosengren A, et al. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia 2012;55:2946-53
   PubMed Web of Science ®Google Scholar
• Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med 2010;268:471-82
   PubMed Web of Science ®Google Scholar
• Nilsson PM, Cederholm J, Eeg-Olofsson K, et al. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register. Eur J Cardiovasc Prev Rehabil 2009;16:506-12
   PubMedGoogle Scholar
• Nilsson PM, Cederholm J, Eeg-Olofsson K, Swedish National Diabetes Register (NDR). Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Diabetes Metab 2009;35:439-46
   PubMedGoogle Scholar
• Sheng X, Murphy MJ, MacDonald TM, Wei L. Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study. Eur J Clin Pharmacol 2012;68:1201-8
   PubMed Web of Science ®Google Scholar
• Kengne AP, Batty GD, Hamer M, et al. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies. Diabetes Care 2012;35:396-403
   PubMed Web of Science ®Google Scholar
• Kengne AP, Czernichow S, Stamatakis E, et al. Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies. Diab Vasc Dis Res 2013;10:143-51
   PubMedGoogle Scholar
• Bruce DG, Van Minnen K, Davis WA, et al. Maternal family history of diabetes is associated with a reduced risk of cardiovascular disease in women with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2010;33:1477-83
   PubMed Web of Science ®Google Scholar
• Ong G, Davis WA, Davis TM. Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2010;53:1288-94
   PubMedGoogle Scholar
• Schimke K, Chubb SA, Davis WA, Davis TM. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010;212:321-6
   PubMedGoogle Scholar
• Xu L, Chan WM, Hui YF, Lam TH. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes. Diabet Med 2012;29:393-8
   PubMedGoogle Scholar
• Luk AO, Ma RC, Lau ES, et al. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 2013;29:384-90
   PubMed Web of Science ®Google Scholar
• Wang Y, Mou Q, Zhao D, et al. Predictive value of ankle-brachial index and blood glucose on the outcomes of six-year all-cause mortality and cardiovascular mortality in a Chinese population of type 2 diabetes patients. Int Angiol 2012;31:586-94
   PubMedGoogle Scholar
• Yang X, Ko GT, So WY, et al. Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: hong Kong Diabetes Registry. Diabetes Care 2008;31:2294-300
   PubMedGoogle Scholar
• Ma RC, Yang X, Ko GT, et al. Effects of systolic and diastolic blood pressures on incident coronary heart disease and all-cause death in Chinese women with Type 2 diabetes: the Hong Kong Diabetes Registry. J Diabetes 2009;1:90-8
   PubMedGoogle Scholar
• Yang X, So WY, Ma RC, et al. Thresholds of risk factors for ischemic stroke in type 2 diabetic patients with and without albuminuria: a non-linear approach. Clin Neurol Neurosurg 2008;110:701-9
   PubMedGoogle Scholar
• Chen XY, Thomas GN, Chen YK, et al. Atherosclerotic vascular disease rather than metabolic syndrome predicts ischemic stroke in diabetic patients. Cerebrovasc Dis 2010;30:374-9
   PubMedGoogle Scholar
• Ting RZ, Lau ES, Ozaki R, et al. High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression–a 7-year prospective analysis of the Hong Kong Diabetes Registry. J Affect Disord 2013;149:129-35
   PubMedGoogle Scholar
• Yang X, Ma RC, So WY, et al. Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus. Cardiovasc Diabetol 2008;7:9
   PubMedGoogle Scholar
• Thomas GN, Chen XY, Lin JW, et al. Middle cerebral artery stenosis increased the risk of vascular disease mortality among type 2 diabetic patients. Cerebrovasc Dis 2008;25:261-7
   PubMed Web of Science ®Google Scholar
• Hayashi T, Araki A, Kawashima S, et al. Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age. Cardiovasc Diabetol 2013;12:10
   PubMedGoogle Scholar
• Sone H, Tanaka S, Tanaka S, et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab 2011;96:3448-56
   PubMed Web of Science ®Google Scholar
• Onodera M, Nakamura M, Tanaka F, et al. Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria. Int Heart J 2012;53:176-81
   PubMedGoogle Scholar
• Bouchi R, Babazono T, Yoshida N, et al. Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes. Hypertens Res 2010;33:1298-304
   PubMed Web of Science ®Google Scholar
• Shinozaki T, Matsuyama Y, Iimuro S, et al. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model. Geriatr Gerontol Int 2012;12(Suppl 1):88-102
   PubMedGoogle Scholar
• Hsieh YT, Tu ST, Cho TJ, et al. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5·5-year prospective analysis. Eur J Clin Invest 2012;42:245-53
   PubMed Web of Science ®Google Scholar
• Chao TF, Leu HB, Huang CC, et al. Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes. Int J Cardiol 2012;156:199-202
   PubMed Web of Science ®Google Scholar
• Gamble JM, Simpson SH, Eurich DT, et al. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab 2010;12:47-53
   PubMed Web of Science ®Google Scholar
• Hirai FE, Moss SE, Klein BE, Klein R. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care 2008;31:493-7
   PubMedGoogle Scholar
• Nichols GA, Joshua-Gotlib S, Parasuraman S. Glycemic control and risk of cardiovascular disease hospitalization and all-cause mortality. J Am Coll Cardiol 2013;62:121-7
   PubMed Web of Science ®Google Scholar
• Zhao W, Katzmarzyk PT, Horswell R, et al. Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab 2013;98:3653-62
   PubMed Web of Science ®Google Scholar
• Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-8
   PubMed Web of Science ®Google Scholar
• Pan A, Lucas M, Sun Q, et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 2011;68:42-50
   PubMed Web of Science ®Google Scholar
• Coleman SM, Katon W, Lin E, Von Korff M. Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort. Psychosomatics 2013;54:428-36
   PubMed Web of Science ®Google Scholar
• Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010;33:264-9
   PubMed Web of Science ®Google Scholar
• Scherrer JF, Garfield LD, Chrusciel T, et al. Increased risk of myocardial infarction in depressed patients with type 2 diabetes. Diabetes Care 2011;34:1729-34
   PubMedGoogle Scholar
• He M, van Dam RM, Rimm E, et al. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation 2010;121:2162-8
   PubMed Web of Science ®Google Scholar
• Li TY, Brennan AM, Wedick NM, et al. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 2009;139:1333-8
   PubMed Web of Science ®Google Scholar
• Zhang WL, Lopez-Garcia E, Li TY, et al. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia 2009;52:810-17
   PubMed Web of Science ®Google Scholar
• Rajpathak SN, Freiberg MS, Wang C, et al. Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: women’s Health Initiative Observational Study. Eur J Nutr 2010;49:211-18
   PubMedGoogle Scholar
• Tohidi M, Hatami M, Hadaegh F, et al. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study. Lipids Health Dis 2010;9:6
   PubMedGoogle Scholar
• Khalili S, Hatami M, Hadaegh F, et al. Prediction of cardiovascular events with consideration of general and central obesity measures in diabetic adults: results of the 8.4-year follow-up. Metab Syndr Relat Disord 2012;10:218-24
   PubMedGoogle Scholar
• Scott R, Donoghoe M, Watts GF, et al. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomized trial. Cardiovasc Diabetol 2011;10:102
   PubMed Web of Science ®Google Scholar
• Batty GD, Li Q, Czernichow S, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol 2010;56:1908-13
   PubMedGoogle Scholar
• Li Q, Chalmers J, Czernichow S, et al. Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2010;53:2320-7
   PubMedGoogle Scholar
• Burgess DC, Hunt D, Li L, et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J 2010;31:92-9
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358(24):2545-59
   PubMed Web of Science ®Google Scholar
• ADVANCE Collaborative Group. Patel A, MacMahon S, Chalmers J, et al. Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358(24):2560-72
   PubMed Web of Science ®Google Scholar
• Sica D. Optimizing hypertension and vascular health: focus on ethnicity. Clin Cornerstone 2004;6(4):28-38
   PubMedGoogle Scholar
• Kenealy T, Elley CR, Collins JF, et al. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol Dial Transplant 2012;27(5):1840-6
   PubMedGoogle Scholar
• Buckalew VMJr, Freedman BI. Effects of race on albuminuria and risk of cardiovascular and kidney disease. Expert Rev Cardiovasc Ther 2011;9(2):245-9
   PubMedGoogle Scholar
• Mather HM, Chaturvedi N, Kehely AM. Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 1998;15(8):672-7
   PubMedGoogle Scholar
• So WY, Raboca J, Sobrepena L, et al. Comprehensive risk assessments of diabetic patients from seven Asian countries: the Joint Asia Diabetes Evaluation (JADE) program. J Diabetes 2011;3(2):109-18
   PubMedGoogle Scholar
• Mohan V, Meera R, Premalatha G, et al. Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India. Postgrad Med J 2000;76(899):569-73
   PubMed Web of Science ®Google Scholar
• Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J 2001;77(908):399-402
   PubMedGoogle Scholar
• Dreyer G, Hull S, Aitken Z, et al. The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease. QJM 2009;102(4):261-9
   PubMedGoogle Scholar
• Bhalla V, Zhao B, Azar KM, et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care 2013;36(5):1215-21
   PubMedGoogle Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63
   PubMed Web of Science ®Google Scholar
• Murakami Y, Huxley RR, Lam TH, et al. Diabetes, body mass index and the excess risk of coronary heart disease, ischemic and hemorrhagic stroke in the Asia Pacific Cohort Studies Collaboration. Prev Med 2012;54:38-41
   PubMedGoogle Scholar
• Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012;308:581-90
   PubMed Web of Science ®Google Scholar
• Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation 2011;124(3):314-23
   PubMed Web of Science ®Google Scholar
• Hyun KK, Huxley RR, Arima H, et al. A comparative analysis of risk factors and stroke risk for Asian and non-Asian men: the Asia Pacific cohort studies collaboration. Int J Stroke 2013;8:606-11
   PubMedGoogle Scholar